Trials / Completed
CompletedNCT01507363
Analgesic Effect of Gabapentin in Total Knee Arthroplasty (TKA)
Analgesic Effect of Perioperative Gabapentin in Total Knee Arthroplasty: A Randomized, Double-blind, Placebo-controlled, Dose-response Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- Hvidovre University Hospital · Academic / Other
- Sex
- All
- Age
- 50 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Pain is a major problem after TKA. Gabapentin may reduce acute postoperative pain. The investigators therefore investigate the effect of Gabapentin as a perioperative analgesic.
Detailed description
Pain is a major problem after TKA. Studies indicate that Gabapentin may reduce acute postoperative pain. However, the optimal dose is unknown and there is constant controversy on analgesic versus side-effects. The investigators therefore investigate the effect of Gabapentin as a perioperative analgesic in a dose-related manner and with a sample-size allowing evaluation of side-effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gabapentin | Tables with Gabapentin (1300 mg/ day) for 7 days, starting on the day of surgery |
| DRUG | Gabapentin | Tables with Gabapentin (900 mg/day) for 7 days, starting on the day of surgery |
| DRUG | Placebo | Placebo tablets for 7 days, starting on the day of surgery |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2012-01-10
- Last updated
- 2014-04-11
Locations
3 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01507363. Inclusion in this directory is not an endorsement.